University of Wisconsin, Madison

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).

1,039 total trials 151 currently recruiting 712 completed early-phase tilt top decile by trial count

University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.

University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.

Top-decile sponsor footprint

University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 56/100

712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,039 total, page 18 of 21

TERMINATED Phase 2

Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum

NCT00580073

COMPLETED

Use of Jumping Mechanography as a Method to Assess Musculoskeletal Status in Older Adults

NCT00596089

COMPLETED NA

Study in the Use of Virtual Reality as an Adjunct to Pain Control in Burn Patients

NCT00591448

COMPLETED

Sexual Functioning in Endometrial Cancer

NCT00543192

COMPLETED Phase 2

Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma

NCT00574171

COMPLETED Phase 4

Improving Cardiovascular Risk Prediction Using Hand Held Carotid Ultrasonography Study

NCT00574457

COMPLETED NA

CT Virtual Proctoscopy for Staging and Volume Assessment for Rectal Cancer

NCT00585728

COMPLETED NA

Improving Women's Health by Using an Electronic Pelvic Floor Questionnaire

NCT00880880

COMPLETED Phase 4

Propofol in Emergence Agitation

NCT00535613

COMPLETED NA

Vitamin D Inadequacy in Rural Populations, Evaluation of Correction by Food Supplementation

NCT00690417

COMPLETED

Thoracic OncoGeriatric Assessment (TOGA) Trials

NCT00591981

COMPLETED Phase 1

Erlotinib and Sunitinib in NSCLC

NCT00581789

TERMINATED NA

Vitamin D for Painful Nocturnal Leg Cramps

NCT00715429

COMPLETED Phase 2

Lithium for Low-Grade Neuroendocrine Tumors

NCT00501540

COMPLETED

Follow-up of Bone Quality in Long-Term Bone Marrow Transplant Survivors

NCT00594295

TERMINATED

Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH

NCT00582868

COMPLETED

Validation Study of Neuropathic Pain

NCT00623961

COMPLETED NA

Preoperative Nutritional Support in Esophagectomy or Pancreaticoduodenectomy

NCT00585624

COMPLETED NA

Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer

NCT00462969

COMPLETED NA

Asthma and Obstructive Sleep Apnea (OSA)

NCT01026298

COMPLETED NA

Clinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy

NCT00692120

COMPLETED NA

Effect of Conjugated Linoleic Acid on Body Fat in Overweight Children

NCT00575991

COMPLETED NA

A Team Model of Hypertension Care in African Americans

NCT00205153

TERMINATED NA

Pilot Study of 18F-FLT PET

NCT00585741

TERMINATED NA

Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients

NCT00585117

COMPLETED NA

Assessing Novel Methods of Improving Patient Education of Nutrition

NCT00394576

COMPLETED

Normal Reference Ranges for Urinary Metabolites and Supersaturation Indices in Pediatric Populations

NCT00591097

COMPLETED Phase 3

Evaluating Improvement Strategies in Addiction Treatment

NCT00934141

COMPLETED NA

A Primary Care Educational Intervention for Families of Overweight Children

NCT00397865

COMPLETED NA

Effect of Montelukast on Experimentally-Induced RV16 Infection in Asthma

NCT00359073

COMPLETED

Normal Control Cohort Sample Bank

NCT00388765

COMPLETED Early Phase 1

Pilot Study on Mindfulness for Tobacco and Alcohol in University Students

NCT01679236

TERMINATED

Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant

NCT00585858

COMPLETED

Evaluation of Supralaryngeal Airway Removal During Initial Resuscitation of the Trauma Patient

NCT00585598

TERMINATED Phase 2

Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer

NCT00574236

COMPLETED NA

Evaluation of Potential Vitamin D Effects on Muscle: a Pilot Study

NCT00593996

COMPLETED Phase 2

Cerebral and Peripheral Perfusion Pilot Study

NCT00751907

COMPLETED

Predictors of Constipation in Healthy Children

NCT00398021

TERMINATED Phase 2

Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer

NCT00585416

COMPLETED Phase 3

Treatment of Childhood Obesity in Primary Care

NCT00398359

COMPLETED

Determining How the Nervous System Processes Pain in Adults With Fibromyalgia

NCT00496886

COMPLETED

Office Practice Assessment of Carotid Atherosclerosis Using Handheld Ultrasound (OPACA) Study

NCT00258973

TERMINATED NA

Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation

NCT00579592

TERMINATED Phase 2

Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation

NCT01053221

COMPLETED

T-score Comparability Between GE Lunar Prodigy and Norland Excel Densitometers

NCT00593437

COMPLETED Phase 3

AZMATICS: AZithroMycin/Asthma Trial In Community Settings

NCT00266851

COMPLETED NA

Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy

NCT00200850

COMPLETED NA

Comparing Angiography: Multislice CT Versus Invasive Heart Catheterization (CACTI)

NCT00284466

COMPLETED

Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)

NCT00585806

TERMINATED NA

Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients

NCT00585611

← Previous Page 18 of 21 Next →

Phase Distribution

PhaseTrial count
Phase 1 109
Phase 2 142
Phase 3 19
Phase 4 79

What is open in the University of Wisconsin, Madison pipeline

151 recruiting of 1,039 indexed (15% open); 712 completed (69%).

Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).

Top condition: Healthy (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Wisconsin, Madison: open-pipeline peers nationwide

Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 6%8%10%12%14%16% Total trials Recruiting share University of Wisconsin, MadisonUniversity of WashingtonBristol-Myers SquibbUniversity of FloridaUniversity of North Carolina, Chapel HillMasonic Cancer Center, University of MinnesotaModernaTXUnited States Naval Medical Center, San DiegoThe Cleveland Clinic
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,039 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this University of Wisconsin, Madison page

1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.

  • 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.